How has Arcus Biosciences's contract with customer, liability changed year-over-year?

Arcus Biosciences's contract with customer, liability decreased by 72.9% year-over-year, from $291M to $79M.

What is the long-term trend for Arcus Biosciences's contract with customer, liability?

Over 2 years (2023 to 2025), Arcus Biosciences's contract with customer, liability has grown at a -55.7% compound annual growth rate (CAGR), from $398M to $78M.

Arcus Biosciences RCUS Contract with Customer, Liability

Contract with Customer, Liability at other companies

ExelixisEXEL

——

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.62B+226%

Enterprise value$3.53B+275%

P/S15.4×+7.5×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's contract with customer, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's contract with customer, liability?: Arcus Biosciences (RCUS) reported contract with customer, liability of $79M in Q1 2026.
How has Arcus Biosciences's contract with customer, liability changed year-over-year?: Arcus Biosciences's contract with customer, liability decreased by 72.9% year-over-year, from $291M to $79M.
What is the long-term trend for Arcus Biosciences's contract with customer, liability?: Over 2 years (2023 to 2025), Arcus Biosciences's contract with customer, liability has grown at a -55.7% compound annual growth rate (CAGR), from $398M to $78M.